Peptide record

TPDB02996

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02996
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 17-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GALRGCWTKSYPPKPCK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C85H134N24O21S2
NDEQHIMFV
KP
1892.27
10.08
4
0
4
+4
1.42
-0.876
28.82
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
7115
3.76
5
Residue Composition
number
1
A
1
R
0
N
0
D
2
C
0
E
0
Q
2
G
0
H
0
I
1
L
3
K
0
M
0
F
3
P
1
S
1
T
1
W
1
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 0 L: 1 K: 3 M: 0 F: 0 P: 3 S: 1 T: 1 W: 1 Y: 1 V: 0
Chemical Descriptors
17 reviewed residue count
C85H134N24O21S2 sequence-only estimate (linear, free termini)
1892.27 sequence-only estimate (linear, free termini)
10.08 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
1.42 sequence-only estimate (linear, free termini)
-0.876 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

% Hemolysis
Hemolysis
20 %
[Ref.14636071] It has 20% hemolytic activity at 100 µM against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Biochemistry. 2003 Dec 2 42(47):14023-14035.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

20% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
20% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. | Biochemistry | 2003
Evidence 3 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.14636071] It has 20% hemolytic activity at 100 µM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochemistry. 2003 Dec 2 42(47):14023-14035.
Evidence 4 Hemolysis

Activity

20 %
% Hemolysis
[Ref.14636071] It has 20% hemolytic activity at 100 µM against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Biochemistry. 2003 Dec 2 42(47):14023-14035.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.